EU Safety Gate (RAPEX) · Sweden · 2024-02-23 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Lodningarna i produkten har en för hög halt av bly (uppmätt värde upp till 61,2 viktprocent). Plastdelarna har en för hög halt av bis(2-etylhexyl)ftalat (DEHP) (uppmätt värde upp till 4,4 viktprocent). Bly utgör en risk för miljön. DEHP kan skada barns hälsa och orsaka möjlig skada på deras reproduktionssystem. Produkten uppfyller inte kraven i direktivet om begränsning av användning av vissa farliga ämnen i elektrisk och elektronisk utrustning (RoHS-direktivet) eller REACH-förordningen.
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Aspirateurs à points noirs
Risk Description (original English): The solders in the product have an excessive concentration of lead (measured value up to 61.2 % by weight). The plastic parts have an excessive concentration of bis(2-ethylhexyl) phthalate (DEHP) (measured value up to 4.4 % by weight).
Lead poses a risk to the environment. DEHP may harm the health of children, causing possible damage to their reproductive system.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.